Autoimmune Disease Industry Statistics

In this post, we explore the latest statistics and trends in the autoimmune disease industry, shedding light on key market insights and projections. From the market size to growth rates, regional analyses, and major players, these statistics provide a comprehensive overview of the current landscape and future prospects within this rapidly evolving sector.

Statistic 1

"Autoimmune Disease Diagnostics market size was valued at over USD 14 billion in 2019."

Statistic 2

"The global autoimmune disease diagnostics market is projected to grow at a CAGR of 8.3% between 2020 to 2025."

Statistic 3

"Rheumatoid Arthritis held around 24% rheumatic disease market share in 2019."

Statistic 4

"The U.S. autoimmune disease diagnostic market generated USD 4.9 billion in 2019."

Statistic 5

"The autoimmune disease therapeutics market is expected to reach USD 153.3 billion by 2027."

Statistic 6

"North America autoimmune disease therapeutics market is expected to hold over 37% share by 2027."

Statistic 7

"The UK rheumatoid arthritis market size surpassed USD 342 million in 2020."

Statistic 8

"China is anticipated to witness over 11% growth in autoimmune disease diagnostics market by 2027."

Statistic 9

"Globally, over 700 million people are affected by autoimmune diseases."

Statistic 10

"The systemic autoimmune disease diagnostics segment reached a market value of USD 9.4 billion in 2020."

Statistic 11

"The autoimmune disease treatment market is expected to increase at CAGR of 4.2% from 2019 to 2027."

Statistic 12

"The European autoimmune disease diagnostics market size surpassed USD 4 billion in 2019."

Statistic 13

"The autoimmune disease diagnostics market in Asia Pacific is expected to register the highest CAGR of 10.0% during the forecast period."

Statistic 14

"The injectable drugs segment held the largest share of 52.6% in the autoimmune disease treatment market in 2019."

Statistic 15

"The antirheumatic drug modality segment was valued at approximately USD 36.8 billion in 2020."

Statistic 16

"By 2024, autoimmune disease diagnostics market in Latin America is projected to reach a market size of USD 1.7 billion."

Statistic 17

"Japan held around 35% of the total Asia Pacific autoimmune disease diagnostics market revenue in 2019."

Statistic 18

"The point-of-care testing segment is expected to expand at a CAGR of 3.9% from 2020 to 2027 in autoimmune disease diagnostics market."

Statistic 19

"The autoimmune disease therapeutics market is predicted to grow at a 4.2% CAGR from 2021 to 2028."

Statistic 20

"The top three companies in the global autoimmune disease diagnostics market in 2019 were Abbott Laboratories, Siemens Healthineers, and bioMerieux SA."

The autoimmune disease industry continues to show significant growth potential, with key statistics indicating a thriving market landscape. With a projected CAGR of 8.3% between 2020 to 2025, the global autoimmune disease diagnostics market is set to expand rapidly. Rheumatoid Arthritis remains a dominant player, holding a substantial market share. The U.S. and North America emerge as pivotal regions for autoimmune disease diagnostics and therapeutics markets, showcasing substantial revenue generation. With an estimated market size of USD 153.3 billion by 2027, the autoimmune disease therapeutics market presents lucrative opportunities for growth and innovation. Various segments within the industry, such as injectable drugs and antirheumatic drug modalities, play integral roles in shaping the market dynamics. Additionally, the increasing prevalence of autoimmune diseases worldwide underscores the need for continued advancements in diagnostics and treatments. As key players like Abbott Laboratories, Siemens Healthineers, and bioMerieux SA lead the way, the industry is poised for ongoing evolution and expansion across global regions.